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Abstract Whole-exome and whole-genome sequencing
(WES, WGS) can generate an unprecedented amount of com-
plex information, making the informed consent (IC) process
challenging. The aim of our study was to assess the readability
of English IC forms for clinical whole-exome and whole-
genome sequencing using the SMOG and Flesch-Kincaid for-
mulas. We analysed 36 forms, most of which were from US
providers. Themedian readability grade levels were 14.75 (the
SMOG formula) and 12.2 (the Flesch-Kincaid formula); these
values indicate the years of education after which a person
would be able to understand a text studied. All forms studied
seem to fail to meet the average recommended readability
grade level of 8 (e.g. by Institutional Review Boards of US
medical schools) for IC forms, indicating that the content of
the forms may not be comprehensible to many patients. The
sections aimed at health care professionals (HCPs) in the
forms indicate that HCPs should be responsible for explaining
IC information to the patients. However, WES and WGS may
be increasingly offered by primary care professionals who
may not (yet) have sufficient training to be able to communi-
cate effectively with patients about genomics. Therefore, to
secure an adequate, truly informed consent process, the task
of developing good, legible examples of IC forms along with
educating HCPs in genomics should be taken seriously, and
adequate resources should be allocated to enable these tasks.
Keywords Informed consent . Readability .Whole genome
sequencing .Whole exome sequencing . Genetic counselling
Introduction
The challenge of informed consent
Informed consent (IC) was introduced into research practice
as an instrument enabling choice about participation in a
study, with the aims to prevent coercion and respect autonomy
of research participants, mostly in response to research mal-
practices that occurred in the last century (Hoeyer 2009). The
Declaration of Helsinki written in 1964 and amended in sub-
sequent years set the standards for more explicit, documented
and specific (i.e. containing a defined set of elements) in-
formed consent in research (World Medical Association
2004). These requirements were gradually implemented both
in research and in the clinical context, becoming an integral
part of routine research and medical care, as well as a legal
requirement in many national legislations (Hoeyer 2009).
However, the process of adopting the requirements for in-
formed consent in different contexts has not all been smooth
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sailing. As a consequence of the growing complexity of med-
ical procedures and knowledge about the associated risks and
implications, informed consent documents have often become
lengthy and difficult to understand (Manson and O’Neill
2007). Reaching the standards of explicit, specific and simul-
taneously truly informed consent may be often very difficult to
achieve—a topic which has been widely debated in academic
literature (Manson and O’Neill 2007). Many studies have re-
ported low levels of readability and/or understandability of
informed consent forms in the USA, which is particularly
worrisome given the prevalence of low levels of (health) lit-
eracy in the population (Sugarman et al. 1999; Paasche-Orlow
et al. 2004). Furthermore, the importance of providing legible
informed consent documents has been supported by medical
malpractice case law (Paasche-Orlow 2005). Importantly, rec-
ognition of the relevance of patients’ perspectives and needs,
as well as the provision of adequate information by a physi-
cian, has given rise to concepts and practices such as shared
decision making (i.e. between physician and patient), patient-
centred care and reasonable-patient informed consent stan-
dards, which have been implemented in the US and UK
healthcare practice (Krumholz 2010; Spatz et al. 2016).
While these approaches stress the role of communication
processes between a physician and patient, they do not
diminish the importance of providing written documents,
which should facilitate the discussion, and can be taken
home by a patient in order to be considered and reflected
upon at the patient’s own pace (Krumholz 2010).
Therefore, adequate readability and comprehensibility of
informed consent forms remain vital elements of the in-
formed consent process.
Informed consent in genetics and genomics
Genetics is a relatively advanced subset of biology, and the
task of successfully communicating genetic concepts to a pub-
lic unfamiliar with the subject can be challenging (McBride
et al. 2010). Explaining issues related to genomics, including
the use of next-generation sequencing in order to perform
whole-exome and whole-genome sequencing (WES, WGS),
adds to this complexity. These approaches generate an unprec-
edented amount of information, potentially about thousands of
phenotypes, including diseases that may also hold relevance
for family members of probands. In addition, the interpreta-
tion of these findings may change with time (Pinxten and
Howard 2014). Whole-genome and whole-exome sequencing
are being increasingly used in research, clinical and direct-to-
consumer settings, and their use is predicted to expand (Rehm
2017). A number of recommendations for informed consent
for WGS have been issued to address this challenge. These
documents outline and discuss the elements that should be
included in the informed consent process and often emphasize
the crucial role of pre-test counselling (Presidential Commission
for the Study of Bioethical Issues 2012; van El et al. 2013;
ACMG Board of Directors 2013; Ayuso et al. 2013).
A few studies analysed the content of IC forms for WGS
and/or WES and discussed the presence (or absence) of a list
of core elements (Jamal et al. 2013; Henderson et al. 2014;
Niemiec et al. 2016). Two of these studies also report on
readability of IC forms (Jamal et al. 2013; Henderson et al.
2014). Henderson and co-authors analysed nine informed
consent forms for WES and WGS studies funded by the US
National Human Genome Research Institute and National
Cancer Institute. Readability was evaluated by the Flesch-
Kincaid formula giving a median of 10.8 grade level, which
indicates that after 10.8 years of education, an average student
would understand most of the text present in the forms
(Henderson et al. 2014). Jamal et al. (2013) analysed six in-
formed consent forms provided by US-based laboratories of-
fering clinical exome sequencing. The median readability
score (Flesch Reading Ease) among documents was 40 (cor-
responding to between high-school and some college grade
levels) (Flesch 1949; Jamal et al. 2013). Both of these studies
indicate that the readability grade level is above the average
recommended grade level of 8 for IC forms as stated by
Institutional Review Boards of US medical schools
(Paasche-Orlow et al. 2003). These results suggest that even
if the forms include the required elements of information, they
may not be comprehensible to many patients since almost half
of Americans read at or below grade level of 8 (Paasche-
Orlow et al. 2003).
Given the particular challenges of communicating informa-
tion about WGS and WES, their increasing use in health care
and the importance of providing the information in a readable
manner, we aimed to provide additional insights into the read-
ability level of a larger sample of informed consent forms for
WGS and WES in the clinical context using two readability
tests.
Methods
Search and inclusion criteria for IC forms
The authors searched for informed consent forms using Google
search engine (www.google.com) applying 12 combinations of
terms from the following groups: (Binformed consent^,
Bconsent document^, Bconsent form^) and (Bwhole genome
sequencing^, Bwhole exome sequencing^, Bnext generation
sequencing^, Bgenome wide sequencing^). The search was
performed between March and April 2016. Two pairs of
authors independently conducted the search using the above
search terms combinations. One hundred links retrieved in
each search-term-combination were accessed and reviewed.
Documents meeting the criteria of consent forms for clinical
WGS/WES in English were included in this study. Consent
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forms developed primarily for research projects and forms that
did not have a space for the patient’s signature were excluded.
Additional consent forms that were not retrieved in the search,
but that were known by the authors from other sources, were
also included. The final collection of forms was read and
studied for a number of different aspects, including infor-
mation on return of results, use of samples and data in
research, as well as readability. Herein, we present only
the results of the readability study.
Characteristics of the forms
The following information was extracted from the IC
forms and/or websites of WGS/WES providers: name of
provider; country of origin; type of provider (type 1: uni-
versities/hospitals/medical centres and their Bin-house^
and/or owned laboratories; type 2: laboratories/companies
not related to a university/hospital/medical centre); for
what type of test a form is used (WES or WGS or both);
and who can be tested (child, adult). This information was
obtained independently by two authors and discrepancies
were resolved in discussion.
Readability
Preparation for analysis
The forms were prepared for the readability analysis by
directly converting files from an original portable docu-
ment format (pdf) to a docx file format or by copying
and pasting information from the original document into
a Word docx file. Final versions of converted or copied
files were verified for accuracy with the original file, and
any discrepancies were corrected. Additional sections in-
cluded in the original files with the informed consent
forms were excluded for this analysis (e.g. requisition
forms, tables for patient information, sample information,
address, payment options, clinical information, physi-
cian’s statements, text explicitly aimed at physicians).
Sections of forms addressed to family members submit-
ting a sample for validation of patient’s results were in-
cluded. Headings were also included and each was treat-
ed as a complete sentence, even when there was no pe-
riod in the end. The following phrases and words not
constituting the main part of the informed consent form
text were removed so that the program would not treat
them as full sentences and consequently conflate the
resulting readability scores: address and contact informa-
tion of a provider; indications of fields for signatures,
initials, names, addresses and dates of birth; dates of
updating/creating forms; pages numbers. Website ad-
dresses found anywhere in the text were also removed.
Numerals were fully syllabized (i.e. sounded out) in the
tests used.
Readability measures
A number of different readability tests have been developed
for evaluating reading grade levels. These are based on eval-
uating parameters, such as sentence length and the number of
syllables inwords. The reported grade level indicates the num-
ber of years of education that a personmust have completed to
understand the text assessed. In this study, two tests were used
to assess the readability: the SMOG1 formula developed by
McLaughlin (1969) and the Flesch-Kincaid formula
(McLaughlin 1969; Kincaid et al. 1975). Basic characteristic
of the formulas is shown in Table 1. The Flesch-Kincaid for-
mula is the most commonly used for analysis in recent health
care literature (years 2005–2008), which is likely to be the
result of the embedding of this formula in Microsoft Word
software (Wang et al. 2013). However, the Flesch-Kincaid
formula is expected to predict only about 75% of comprehen-
sion (when validated on multiple-choice test), meaning that a
person who completed the grade level indicated in the test
would be able to comprehend approximately 75% of the text
(Kincaid et al. 1975). Distinctively, the SMOG formula was
developed to predict 100% comprehension (validated using
McCall-Crabbs Standard Test Lessons in Reading based on
multiple choice tests) (McLaughlin 1969). For this reason,
the SMOG appears to be a more adequate test to evaluate
informed consent forms for which 100% comprehension is
expected (Wang et al. 2013). Hence, we used the SMOG
test as the main evaluative calculation, although we also
employed the Flesch-Kincaid formula to obtain results
comparable to other studies using this test. Calculation of
readability for the two groups of IC forms (type 1 and type
2, Table 3) was conducted using the SMOG test. The re-
sults obtained for these two groups were compared using
Mann-Whitney statistical test.
Both tests were performed using the software Readability
Studio Professional Edition for Windows, version 2015
(Oleander Software Ltd., Vandalia, Ohio). The calcula-
tions were based on the whole text (and not subsamples
of the text) and standardized if needed. Additionally, we
calculated the word count of informed consent docu-
ments as a rough indicator of the time required to read
the text.
1 SMOG is often referred to as Simple Measure of Gobbledygook in the
literature; however, in the author’s intention, it is a reference to another read-
ability grading formula (Gunning’s Fog Index (Gunning 1968)): BI call my
system of readability prediction SMOG Grading in tribute to Gunning’s Fog
Index (The term also refers to my birthplace, smog having first appeared in
London, though, like so many other things, it has since been improved upon in
several American cities)^. (McLaughlin 1969)
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Information about the informed consent process
In order to have some insight into the informed consent pro-
cess, we also report on the presence of statements mentioning
pre-test counselling as well as the sections of the forms aimed
directly at health care professionals (HCPs).
Results
Characteristics of forms
We identified 36 informed consent forms for clinical WGS/
WES in English: 32 forms were retrieved through the Google
search; 4 forms were identified from WES/WGS providers
with which the authors were familiar. The majority of forms
come from various types of providers in the USA, are used for
WES and are targeted at both adult and children patients. The
complete list of form characteristics is outlined in Table 2.
Readability results
Figures 1 and 2 illustrate the results of the SMOG and the
Flesch-Kincaid formulas. The range of grade level scores for
the SMOG formula was 12.7–18.4, with a mean grade level of
14.8 and median of 14.75. For Flesch-Kincaid, the range was
10.3–16.4; mean 12.5 and median of 12.2. The word count
ranged between 204 and 3017 words, with a mean of 1679
words and median of 1489. Figure 3 and Table 3 include the
values for the SMOG formula and word count obtained in two
groups of IC forms: universities/hospitals/medical centres and
their Bin-house^ and/or owned laboratories (type 1) and
laboratories/companies not associated with a university/hos-
pital/medical centre (type 2). No significant differences were
found between the two groups with respect to word count or
readability grade levels.
Table 1 Information regarding the readability formulas used to analyse consent forms
Flesch-Kincaid formula SMOGa formula
Original development and reference The formula has been designed for evaluating
readability
of technical texts for US military by Kincaid
(Kincaid et al. 1975).
McLaughlin (McLaughlin 1969)
Analysis based on Sentence length and syllable count Number of complex words (3 and more syllables)
Easier formula for manual calculation
(not used in this study)
G = (12*(B/W)) + (0 .4*(W/S)) – 16
G—grade level
W—number of words
B—number of syllables
S—number of sentences
G = FLOOR(√C) + 3
G—grade level
C—number of complex words (3 and more
syllables)
FLOOR—round the result of (√C) down to the
closest perfect square.
Higher precision formula used by the
software in this study
G = (11.8*(B/W)) + (0.39*(W/S)) − 15.59 G = 1.0430*√C + 3.1291
aOriginally, McLaughlin recommended using 10 consecutive sentences from the beginning of the text, 10 sentences from the middle and 10 from the
end; the formula was meant to facilitate manual calculations. In our study, the calculations were based on the whole text (and not subsamples of the text)
and standardized
Table 2 Information about IC forms: the country of origin, provider,
type of test, groups to which it is offered
Characteristics Number of forms
Total number of forms 36
Country of origin
USA 29
Germany 2
The Netherlands 2
Australia 1
Canada and Germany 1
Finland 1
Provider
Type 1: university/hospital/medical centre
and their Bin-house^ and/or owned
laboratories
18
Type 2: company/laboratory not related to a
university/hospital/medical centre
18
Type of test
WGS 5
WES 24
WGS and WES 4
WGS, WES and another genetic test 3
Target group
Only adults 3
Only children 1
Adults and children 30
Not specified 2
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Information about informed consent process
Thirty-two of the forms mentioned some form of pre-test ge-
netic counselling outlining, for example, that patients should
consider, seek and/or obtain pre-test genetic counselling, or
that pre-test genetic counselling is recommended/required.
Twenty-one forms included text aimed at a HCP stating that
a HCP has provided/discussed relevant IC information and/or
offered/ensured providing of pre-test counselling.
Discussion
Very low readability of IC forms
All of the 36 forms studied have a higher reading grade level
than that recommended (by US medical schools Institutional
Review Boards) for IC forms, which is, on average, a grade
level of 8 (Paasche-Orlow et al. 2003). The values obtained in
the SMOG calculation are higher than those from the Flesch-
Kincaid. This result is expected as the SMOG formula aims to
predict 100% comprehension, while the Flesch-Kincaid for-
mula would predict only about 75% comprehension (when
validated on multiple choice test) (McLaughlin 1969;
Kincaid et al. 1975). Our results correspond with the relatively
high reading grade levels of informed consent forms obtained
by Jamal et al. (2013) and Henderson et al. (2014), which
indicated the median grade level of high-school to some col-
lege in the Flesch Reading Ease formula, and median of 10.8
grade level with the Flesch-Kincaid formula, respectively
(Flesch 1949; Jamal et al. 2013; Henderson et al. 2014). The
word count of the IC forms we studied ranged from 204 to
3017 words, with a mean of 1679 words and median of 1489,
suggesting that a person would need, at least, between 1 and
15 min to read the informed consent form content aimed at
patients (assuming the pace of reading of 200 words per min-
ute) (Bell 2001). However, given the fact that the readability
of the texts studied is low, an average patient would probably
need much more time to assimilate the content of an IC form.
These findings are in line with those of Jamal et al. (2013),
which indicate the median word count among the six studied
IC forms for WES is 1154, and the range is 724 to 3429 words
(Jamal et al. 2013). Both the results herein and Jamal et al.’s
word count results are lower than the values obtained by
Henderson et al. (2014) in a study of 9 IC forms for WES/
WGS (mean = 4588 words, range 2917–5757 words) (Jamal
et al. 2013; Henderson et al. 2014). This difference may be
related to the fact that Henderson et al. (2014) analysed
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consent forms used in a research context, and these may have
contained additional information such as about the study de-
sign (Henderson et al. 2014).
The results indicating low readability of IC forms are not
surprising, particularly when comparing them to studies of IC
forms in the context of other medical procedures (Sugarman
et al. 1999). However, it is interesting that none of the forms in
this study, or other previous studies investigating IC forWGS,
reaches the average recommended readability level of 8th
grade (Henderson et al. 2014; Jamal et al. 2013). This indi-
cates that IC forms may fail to fulfil their intended function of
providing understandable information to patients and facilitat-
ing communication. The high scores obtained in the SMOG
and Flesch-Kincaid formulas indicate that the documents
studied use many complex, long words, which may often be
technical and therefore difficult to understand to an average
reader. Indeed, some sections of IC form text were difficult to
understand even for the authors; one could imagine that it
would be even more complicated for a person not familiar
with vocabulary used in genetics, for instance:
Diagnostic findings not related to phenotype in child-
hood onset conditions—a single pathogenic or likely
pathogenic variant in genes that are known to cause
autosomal dominant or X-linked childhood onset
conditions, as well as two pathogenic or likely path-
ogenic variants in genes that are known to cause
autosomal recessive childhood onset conditions, even
if they are unrelated to the patient's phenotype, will
be reported. (IC form number 18. The length of this
sentence is 64 words; the score in the SMOG formula
is 19).
This lack of adequate provision of information in IC forms
appears particularly worrisome given that some of the compa-
nies offering WES/WGS included in this study also advertise
the tests directly to consumers. In the direct-to-consumer ad-
vertising context, consumers may be provided with encourag-
ing information about the benefits of the testing on the com-
panies’ websites, and unless explained in the IC process, they
may not be aware of all the limitations and risks of the testing
(Singleton et al. 2012). The need for legible IC forms seems to
be even more relevant when WGS and WES is offered to
minors; if possible, consent or assent should be obtained from
children when testing is offered (American Academy of
Paediatrics 2013). Therefore, clear and informative content
of IC forms can be very valuable in this context.
Since we hypothesized that the potentially greater presence
and involvement of HCPs in designing IC forms might result in
increased readability of the forms, we assigned the IC forms to
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Table 3 Grade levels obtained for two categories of IC forms. TheMaan-Whitney test was used for comparison of results between these two groups of
test providers
Type 1: universities/hospitals/medical centres and
their Bin-house^ and/or owned laboratories
Type 2: laboratories/companies not associated
with a university/hospital/medical centre
p value and Z-score
Grade level SMOG Range 12.9–17; median 14.5 Range 12.7–18.4
Median 15.4
Z = 1.61
p = 0.1
Word count Range 204–3017; median 1405 Range 544–2785; median 1541 Z = 0.17
p = 0.85
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two different groups, assuming that the involvement of HCPs is
higher in the first group: group 1—university/hospital/medical
centres and their "in-house" and/or owned laboratories; group
2—companies/laboratories not associated with a medical cen-
tre/hospital/university. Readability and word count was com-
pared among these groups (Table 3 and Fig. 3). No statistically
significant differences were found between these two IC form
types with regard to readability scores and word count. These
results suggest that involvement of health care professionals/
genetic counsellors with experience in communication may be
similar in these two groups. Indeed, the recent data indicate that
an increasing number of genetic counsellors work in diagnostic
laboratories (Waltman et al. 2016). The process of designing
informed consent forms, including the involvement and roles of
various experts may be worth investigating further.
Role of a HCP in the informed consent process
The requirement or suggestion to undergo pre-test counselling
present in many forms studied, as well as the sections of text
stating that a HCP has provided relevant information to the
patient (which often should be signed by a HCP) seem to place
an obligation on HCPs and genetic counsellors. These state-
ments imply that the physician is responsible for ensuring that
the patient is adequately informed and understands the infor-
mation provided, even if the consent form is not easy to com-
prehend. Consequently, given the low readability of the forms
and the stated obligation of a HCP to explain the relevant
information, IC forms in this context may take a role of a
Bchecklist^ for a HCP indicating which elements (s)he should
explain to a patient, rather than being a sole explanatory ma-
terial for a patient. Indeed, a study by Bernhardt et al. (2015)
showed that during pre-test counselling sessions for genomic
sequencing, genetic counsellors and research coordinators
modified and adjusted (depending on the context) the infor-
mation provided to the patients from that presented in the IC
forms (Bernhardt et al. 2015). Moreover, the study reported
that genetic counsellors and research coordinators Brecognized
that most patients and participants cannot attend to, let alone
understand, all of the information contained in the consent
documents^ (Bernhardt et al. 2015). Undoubtedly, the HCP’s
role (and often obligation) to communicate and provide infor-
mation is vital for the IC process, not only for genomic testing
but in the context of all clinical procedures or tests requiring
informed consent. However, considering the predictions that
genomics is likely to become part of mainstream practice in
medicine, WGS and WES may be increasingly offered by
primary care professionals who may not yet have sufficient
training or experience to be able to communicate effectively
with patients about genomics (Christensen et al. 2016). In
such cases, primary care professionals may be more depen-
dent on IC forms as a communication tool to explain WGS/
WES to patients. Consequently, in these circumstances, the
explanatory and educational role of informed consent
forms should not be underestimated.
The appropriate means of communicating about genomics in
IC forms (e.g. usage of understandable vocabulary, length of
document etc.) need to be explored, implemented, monitored
and revised as needed. To obtainmore comprehensive evaluation
of the functionality of informed consent forms, additional
methods, such as Suitability Assessment of Materials could be
applied (Kloza et al. 2015). Furthermore, insights from health
professionals who have experience in obtaining informed con-
sent for genomic testing could help improve the quality of in-
formed consent forms. For example, the issues indicated by ge-
netic counsellors asmost important for patients andmost likely to
be misunderstood could gain more attention when designing
informed consent forms. In addition, reducing the length of other
(potentially less relevant to informed consent) sections of IC
forms such as descriptions of the technical aspects of sequencing
might increase the readability of the forms (Bernhardt et al.
2015). Furthermore, investigating patients’ needs and under-
standing when communicating about genomics could be another
important element in the effort to design adequate informed con-
sent information (Parry and Middleton 2017).
Limitations
The limitations of this study include, firstly, that the consent
forms were collected at one given point of time, in one lan-
guage (English) using a specific strategy aimed at finding
documents available online. We acknowledge that we may
have missed some documents that are currently in use but
not publicly available online, and that the studied forms we
found may no longer be in use. The study of additional forms
in other languages than English could also be of value.
Secondly, there are limitations inherent to the readability for-
mulas used. For example, not all the (potentially) difficult
words have more than two syllables (for instance Bgenome^).
Furthermore, the readability formulas do not evaluate all the
elements influencing readability, for example, graphic design,
font type and size and document layout. Finally, readability
and comprehension are distinctive measures. However, the
SMOG and Flesch-Kincaid formulas were validated in tests
aiming at evaluating comprehensibility; it has been questioned
whether some of them accurately reflect comprehension
(Wang et al. 2013). Therefore, the readability results only
provide an estimation of comprehensibility of informed con-
sent forms. In order to evaluate factual understanding of the
documents, a study surveying patients should be conducted.
Conclusions
Based on the 36 IC forms identified, our results suggest that
the IC forms for use in WES/WGS in the clinic may not
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adequately fulfil their function of explaining relevant in-
formation to patients. This function seems to be trans-
ferred to some extent to genetic counsellors and/or health
care professionals, which may be problematic if a HCP
does not have sufficient training in genomics to be able to
explain the information to patients. Therefore, moving
forward, along with educating HCPs in genomics, it will
be essential for good examples of informed consent forms
to be developed that will communicate relevant informa-
tion effectively and facilitate the process of informed con-
sent. Engaging expert groups including clinical geneti-
cists, genetic counsellors, communication professionals
and patients may facilitate this task. In order to ensure
responsible implementation of genomic technologies, se-
curing an adequate, truly informed consent process should
be taken seriously and adequate resources should be allo-
cated to enable fulfilling this task.
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